RESUMEN
Stromal cells are key components of the tumour microenvironment (TME) and their incorporation into 3D engineered tumour-stroma models is essential for tumour mimicry. By engineering tumouroids with distinct tumour and stromal compartments, it has been possible to identify how gene expression of tumour cells is altered and influenced by the presence of different stromal cells. Ameloblastoma is a benign epithelial tumour of the jawbone. In engineered, multi-compartment tumouroids spatial transcriptomics revealed an upregulation of oncogenes in the ameloblastoma transcriptome where osteoblasts were present in the stromal compartment (bone stroma). Where a gingival fibroblast stroma was engineered, the ameloblastoma tumour transcriptome revealed increased matrix remodelling genes. This study provides evidence to show the stromal-specific effect on tumour behaviour and illustrates the importance of engineering biologically relevant stroma for engineered tumour models. Our novel results show that an engineered fibroblast stroma causes the upregulation of matrix remodelling genes in ameloblastoma which directly correlates to measured invasion in the model. In contrast the presence of a bone stroma increases the expression of oncogenes by ameloblastoma cells.
RESUMEN
PURPOSE: Radiation therapy-induced xerostomia significantly affects quality of life in head and neck cancer survivors. Neuro-electrostimulation of the salivary glands may safely increase natural salivation and reduce dry mouth symptoms. METHODS AND MATERIALS: This multicenter, double-masked, randomized, sham-controlled clinical trial assessed the long-term effects of a commercially available intraoral neuro-electrostimulating device in lessening xerostomia symptoms, increasing salivary flow, and improving quality of life in individuals with radiation therapy-induced xerostomia. Using a computer-generated randomization list, participants were assigned (1:1) to an active intraoral custom-made removable electrostimulating device or a sham device to be used for 12 months. The primary outcome was the proportion of patients reporting a 30% improvement on the xerostomia visual analog scale at 12 months. A number of secondary and exploratory outcomes were also assessed through validated measurements (sialometry and visual analog scale) and quality-of-life questionnaires (EORTC QLQ-H&N35, OH-QoL16, and SF-36). RESULTS: As per protocol, 86 participants were recruited. Intention-to-treat analyses showed no statistical evidence of a difference between the study groups with respect to the primary outcome or for any of the secondary clinical or quality-of-life outcomes. Exploratory analyses showed a statistically significant difference in the changes over time of the dry mouth subscale score of the EORTC QLQ-H&N35 in favor of the active intervention. CONCLUSIONS: LEONIDAS-2 did not meet the primary and secondary outcomes.
Asunto(s)
Terapia por Estimulación Eléctrica , Neoplasias de Cabeza y Cuello , Traumatismos por Radiación , Xerostomía , Humanos , Calidad de Vida , Xerostomía/etiología , Xerostomía/terapia , Salivación , Glándulas Salivales , Neoplasias de Cabeza y Cuello/radioterapia , Traumatismos por Radiación/terapia , Terapia por Estimulación Eléctrica/métodosRESUMEN
Treatment of xerostomia is a common clinical challenge in the oral medicine practice. Although some treatmentshave been used to improve the symptoms of xerostomia, none is completely satisfactory for the patients who sufferof this alteration. In the last years non-pharmacological treatments based on electro-stimulation for the treatmentof xerostomia have been developed. This review is aimed at presenting new developments for the treatmentof xerostomia, applying neuro-electro-stimulation by miniaturized intra-oral electro-stimulators. These devicesincrease salivary secretion and improve symptoms of oral dryness. Their effect is obtained by means of stimulationof the lingual nerve, in whose proximity the electrodes of the apparatus are placed. The objective of thismechanism is both to directly stimulate the salivary glands controlled by that nerve and to enhance the salivaryreflex. Clinical studies have been carried out that have demonstrated the wetting effect of the method describedin this article (AU)